| Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents G Kampf, D Todt, S Pfaender, E Steinmann Journal of hospital infection 104 (3), 246-251, 2020 | 5433 | 2020 |
| Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols A Kratzel, D Todt, P V’kovski, S Steiner, M Gultom, TTN Thao, N Ebert, ... Emerging infectious diseases 26 (7), 1592, 2020 | 455 | 2020 |
| Virucidal activity of World Health Organization–recommended formulations against enveloped viruses, including Zika, Ebola, and emerging coronaviruses A Siddharta, S Pfaender, NJ Vielle, R Dijkman, M Friesland, B Becker, ... The Journal of infectious diseases 215 (6), 902-906, 2017 | 260 | 2017 |
| Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2 TL Meister, Y Brüggemann, D Todt, C Conzelmann, JA Müller, R Groß, ... The Journal of infectious diseases 222 (8), 1289-1292, 2020 | 220 | 2020 |
| LY6E impairs coronavirus fusion and confers immune control of viral disease S Pfaender, KB Mar, E Michailidis, A Kratzel, IN Boys, P V’kovski, W Fan, ... Nature microbiology 5 (11), 1330-1339, 2020 | 192 | 2020 |
| In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome D Todt, A Gisa, A Radonic, A Nitsche, P Behrendt, PV Suneetha, ... Gut 65 (10), 1733-1743, 2016 | 191 | 2016 |
| Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease L van de Sand, M Bormann, M Alt, L Schipper, CS Heilingloh, ... Viruses 13 (4), 609, 2021 | 161 | 2021 |
| Temperature-dependent surface stability of SARS-CoV-2 A Kratzel, S Steiner, D Todt, P V'kovski, Y Brueggemann, J Steinmann, ... Journal of Infection 81 (3), 452-482, 2020 | 130 | 2020 |
| Extra‐hepatic replication and infection of hepatitis E virus in neuronal‐derived cells SA Drave, Y Debing, S Walter, D Todt, M Engelmann, M Friesland, ... Journal of viral hepatitis 23 (7), 512-521, 2016 | 119 | 2016 |
| Persistence of pathogens on inanimate surfaces: a narrative review JE Wißmann, L Kirchhoff, Y Brüggemann, D Todt, J Steinmann, ... Microorganisms 9 (2), 343, 2021 | 115 | 2021 |
| Antiviral activities of different interferon types and subtypes against hepatitis E virus replication D Todt, C François, Anggakusuma, P Behrendt, M Engelmann, ... Antimicrobial agents and chemotherapy 60 (4), 2132-2139, 2016 | 89 | 2016 |
| The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo D Todt, N Moeller, D Praditya, V Kinast, M Friesland, M Engelmann, ... Antiviral research 157, 151-158, 2018 | 85 | 2018 |
| Rapid quantification of SARS-CoV-2-neutralizing antibodies using propagation-defective vesicular stomatitis virus pseudotypes F Zettl, TL Meister, T Vollmer, B Fischer, J Steinmann, A Krawczyk, ... Vaccines 8 (3), 386, 2020 | 84 | 2020 |
| Hepatitis E: An update on One Health and clinical medicine TP Velavan, SR Pallerla, R Johne, D Todt, E Steinmann, M Schemmerer, ... Liver International 41 (7), 1462-1473, 2021 | 83 | 2021 |
| Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation Anggakusuma, I Romero‐Brey, C Berger, CC Colpitts, T Boldanova, ... Hepatology 62 (3), 702-714, 2015 | 78 | 2015 |
| Hepatitis E virus infection: circulation, molecular epidemiology, and impact on global health SR Pallerla, D Harms, R Johne, D Todt, E Steinmann, M Schemmerer, ... Pathogens 9 (10), 856, 2020 | 73 | 2020 |
| Cell culture systems for the study of hepatitis E virus TL Meister, J Bruening, D Todt, E Steinmann Antiviral research 163, 34-49, 2019 | 73 | 2019 |
| Development and virucidal activity of a novel alcohol-based hand disinfectant supplemented with urea and citric acid G Ionidis, J Hübscher, T Jack, B Becker, B Bischoff, D Todt, V Hodasa, ... BMC infectious diseases 16, 1-10, 2016 | 72 | 2016 |
| Robust hepatitis E virus infection and transcriptional response in human hepatocytes D Todt, M Friesland, N Moeller, D Praditya, V Kinast, Y Brüggemann, ... Proceedings of the National Academy of Sciences 117 (3), 1731-1741, 2020 | 71 | 2020 |
| Hepatitis E virus (HEV) ORF2 antigen levels differentiate between acute and chronic HEV infection P Behrendt, B Bremer, D Todt, RJP Brown, A Heim, MP Manns, ... The Journal of infectious diseases 214 (3), 361-368, 2016 | 63 | 2016 |
